# Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand Therapy

> **NCT07587814** · NA · NOT_YET_RECRUITING · sponsor: **Centre Henri Becquerel** · enrollment: 100 (estimated)

## Conditions studied

- Carcinoma
- Castration Resistant Prostatic Neoplasms

## Interventions

- **RADIATION:** 177Lu-PSMA-617 + SPECT/CT dosimetry

## Key facts

- **NCT ID:** NCT07587814
- **Lead sponsor:** Centre Henri Becquerel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-09
- **Final completion:** 2029-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07587814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07587814, "Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand Therapy". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT07587814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*